Xu, J., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States; Wang, W., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States; Xu, L., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States; Chen, J.-Y., Department of Cellular and Molecular Medicine, University of California San Diego, San diego, CA 92093, United States; Chong, J., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States; Oh, J., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States; Leschziner, A.E., Department of Cellular and Molecular Medicine, University of California San Diego, San diego, CA 92093, United States, Section of Molecular Biology, Division of Biological Sciences, University of California San Diego, San diego, CA 92093, United States; Fu, X.-D., Department of Cellular and Molecular Medicine, University of California San Diego, San diego, CA 92093, United States; Wang, D., Division of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San diego, CA 92093, United States, Department of Cellular and Molecular Medicine, University of California San Diego, San diego, CA 92093, United States
Recommended Citation:
Xu J.,Wang W.,Xu L.,et al. Cockayne syndrome B protein acts as an ATP-dependent processivity factor that helps RNA polymerase II overcome nucleosome barriers[J]. Proceedings of the National Academy of Sciences of the United States of America,2020-01-01,117(41)